Delivery Order SPE2DB22D3401-SPE2DB25FT3VB

Award Date 5/20/25
Potential Completion Date 5/21/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) has awarded a $2,637.18 firm-fixed-price delivery order to Amerisourcebergen Drug Corporation's Corporate Office Division for the supply of 4559141955 - Dimethyl Fumarate DR 240 MG CP 60S. This delivery order is placed under Indefinite Delivery Contract (IDC) SPE2DB23FY94N, a large medical supply contract with a ceiling value of up to $999,999,999 that runs through December 2025. Amerisourcebergen, a major pharmaceutical distributor, has been providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $37,492.76, is a firm-fixed-price delivery order with an ultimate completion date of April 29, 2025. The contract provides for the delivery of a variety of pharmaceutical products and medical supplies, including medications across multiple therapeutic domains such as diabetes, neurology,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,343.59, is for the delivery of pharmaceutical and medical products to support the DLA's Pharmaceutical Division - Force Sustainment Branch (FSB). The contract is a firm fixed-price delivery order with an ultimate completion date of April 28, 2025. It is not designated as a set-aside contract, indicating open...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,124.64 firm fixed-price contract is for the supply of various pharmaceutical products and medical supplies, including medications across multiple therapeutic domains such as diabetes, neurology, pain management, and antibiotics. The contract has an...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,746.38, is a firm fixed-price delivery order with an ultimate completion date of April 18, 2025. The contract is not set aside and allows for the delivery of a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,570.15 and an ultimate completion date of April 16, 2025. The contract is not set aside and allows for the delivery of a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications across various...
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Medical Supply Chain. The $13,920.91 firm fixed-price contract is for the delivery of various pharmaceutical and medical products, including medications across therapeutic categories such as diabetes, neurology, pain management, and antibiotics. The contract has an ultimate completion date of May 23, 2025 and is not set aside....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,768.70 firm-fixed-price contract is for the delivery of a range of pharmaceutical and medical products, including medications across various therapeutic areas such as diabetes, neurology, pain management, and specialty pharmaceuticals, as well as medical supplies. The contract has an ultimate...
This is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $3,965.49 contract is for the delivery of various pharmaceutical and medical products, including medications across multiple therapeutic areas such as diabetes, neurology, and pain management, as well as specialized medical supplies. The contract has an ultimate completion date of May 6, 2025. Amerisourcebergen Drug Corp holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price of $1,223.59 and a completion date of June 16, 2025. The contract is not a set-aside and is for the delivery of various pharmaceutical products and medical supplies, including medications across multiple therapeutic domains such as diabetes, neurology, and pain...
  • SPE2DB22D3401
    Indefinite Delivery Contract
  • SPE2DB22D3401-SPE2DB25FT3VB
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Dimethyl Fumarate DR 240 MG CP 60S. The contract has a firm fixed price of $1,092.12 and a completion date of May 21, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This contract enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.

Generated 8/24/25, 1:14 AM